These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Role of quisqualic acid receptors in the hypermotility response produced by the injection of AMPA into the nucleus accumbens.
    Author: Shreve PE, Uretsky NJ.
    Journal: Pharmacol Biochem Behav; 1988 Jun; 30(2):379-84. PubMed ID: 2902646.
    Abstract:
    alpha-Amino-3-hydroxy-5- methylisoxazole-4-propionate (AMPA) is an excitatory amino acid which on the basis of electrophysiological and binding studies appears to act as a quisqualic acid receptor agonist. AMPA and other excitatory amino acids, such as quisqualic acid, kainic acid, and N-methyl-D-aspartic acid, as well as picrotoxin, an inhibitor of endogenous GABA, produce a marked stimulation of locomotor activity after bilateral injection into the nucleus accumbens. The intraacumbens injection of gamma-D-glutamylaminomethylsulphonate (GAMS) was found to inhibit the hypermotility responses produced by AMPA and quisqualic acid at doses that were unable to inhibit the hypermotility responses produced by kainic acid, N-methyl-D-aspartic acid, and picrotoxin. These results suggest that GAMS is able to selectively inhibit quisqualic acid receptors in the nucleus accumbens. The intraacumbens injection of D-alpha-aminoadipic acid at a dose that significantly inhibited N-methyl-D-aspartic acid-stimulated locomotor activity did not produce a significant inhibition of AMPA-stimulated locomotor activity, suggesting that AMPA is not acting at N-methyl-D-aspartic acid receptors. Thus, these results suggest that the activation of quisqualic acid receptors in the nucleus accumbens produces a hypermotility response.
    [Abstract] [Full Text] [Related] [New Search]